TWOEquity · Weekly research terminal

6483

Original BioMedicals Co., Ltd.

TW Healthcare Drug Manufacturers - Specialty & Generic

Latest week
14 Aug 2026
Weekly close
14.05 TWD
Fair value
13.96 TWD
Next-week expectancy
Negative 44.26%
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TWO · Equity · Taiwan

6483

Original BioMedicals Co., Ltd.

Healthcare Drug Manufacturers - Specialty & Generic

Original BioMedicals Co., Ltd. engages in the development of drugs in Taiwan. The company develops OBM-A01, a radiation injury prevention and therapeutic drug for the treatment of acute radiation injuries, including nuclear radiation and solar radiation exposure in space; OBM-B01, a cyanide compound drug for protection against toxic gases from fires; CCM-CL, a cyclic polypeptide antibiotic; and Iron Dextran, an injection for the treatment of iron deficiency. It also provides NE (vitamin …

Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
TWD
Market capitalisation
942,234,304
Fair value reference
13.96
Next-week expectancy
Negative · 44.26%

Over the latest 12 completed weeks ending 2026-08-14, 6483 rose 5.24%, moving from 13.35 to 14.05. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -25.94 and has improved across the 12-week window. Market Dynamics is -0.08 on the latest week. Next-week expectancy is negative at 44.26% based on similar historical setup states.

Week Ending
14 Aug 2026
Latest Close
14.05
12-Week Change
5.24%
Trend Signal
Inactive
Next-Week Expectancy
Negative 44.26%
Signal Weeks
0 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
14 Aug 2026
Latest Close
14.05
12-Week Change
5.24%
Trend Signal
Inactive
Next-Week Expectancy
Negative 44.26%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
-25.94
Market Dynamics
-0.08

Over the latest 12 completed weeks ending 2026-08-14, 6483 rose 5.24%, moving from 13.35 to 14.05. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -25.94 and has improved across the 12-week window. Market Dynamics is -0.08 on the latest week. Next-week expectancy is negative at 44.26% based on similar historical setup states.

Industry Peers

Taiwan equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
6446 PharmaEssentia Corporation TAI 14 Aug 2026 1200.00 1550.00 1190.00 1500.00 25.00%
6932 Merdury Biopharmaceutical Corporation TWO 14 Aug 2026 5.13 8.63 5.01 6.02 17.35%
7829 Yoda Pharmaceuticals Inc. TWO 14 Aug 2026 39.85 46.35 39.85 44.90 12.67%
4747 Johnson Chemical Pharmaceutical Works Co., Ltd. TWO 14 Aug 2026 49.70 58.10 49.70 54.50 9.66%
6467 TAHO Pharma TWO 14 Aug 2026 114.00 130.00 114.00 125.00 9.65%
6621 UniPharma Co., Ltd. TWO 14 Aug 2026 11.00 11.95 10.60 11.65 5.91%
6539 DV Biomed Co., Ltd. TWO 14 Aug 2026 40.30 42.40 38.30 42.40 5.21%
4172 InnoPharmax Inc. TWO 14 Aug 2026 10.95 11.45 10.70 11.45 4.57%
1780 Allied Biotech Corporation TWO 14 Aug 2026 22.75 23.75 22.30 23.75 4.40%
6785 Alar Pharmaceuticals Inc. TWO 14 Aug 2026 98.10 104.00 96.50 100.00 1.94%
4114 Synmosa Biopharma Corporation TWO 14 Aug 2026 29.30 30.15 29.05 29.80 1.71%
3705 YungShin Global Holding Corporation TAI 14 Aug 2026 53.50 54.50 53.00 54.30 1.50%
7860 TEH SENG TWO 14 Aug 2026 71.20 74.00 68.50 72.00 1.12%
4108 PhytoHealth Corporation TAI 14 Aug 2026 11.15 11.25 10.90 11.25 0.90%
6576 Foresee Pharmaceuticals Co., Ltd. TWO 14 Aug 2026 79.00 80.70 78.70 79.70 0.89%
6677 Anxo Pharmaceutical Co., Ltd. TWO 14 Aug 2026 16.00 16.50 16.00 16.10 0.63%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context